184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study

Autor: Ajuria, L. Carril, Naigeon, M., Flippot, R., Dalban, C., Desnoyer, A., Rioux-Leclercq, N., Sautes-Fridman, C., Meylan, M., Vano, Y., Beuselinck, B., Chouaib, S., de Oliveira, C., Tantot, F., Escudier, B., Chaput-Gras, N., Albiges, L.

Publikováno v: In Immuno-Oncology and Technology December 2023 20 Supplement

1710P Exposure-response (E/R) relationship of nivolumab (N) and ipilimumab (I) in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) from the randomised phase II BIONIKK study

Autor: Blanchet, B., Puszkiel, A.A., Jouinot, A., Bennamoun, M., Maillet, D., Borchiellini, D., Laguerre, B., Pannier, D., Gross Goupil, M., Chevreau, C.M., Barthelemy, P., Tournigand, C., Coquan, E., Gravis, G., Kotti, S., Fridman, W-H., Sautes-Fridman, C., Oudard, S., Sun, C-M., Vano, Y-A.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S1025-S1025

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

Autor: Ajuria, L. Carril, Naigeon, M., Dalban, C., Desnoyer, A., Rioux-Leclercq, N., Sautes-Fridman, C., Meylan, M., Vano, Y., Beuselinck, B., Chouaib, S., De Oliveira, C., Tantot, Olivier, Escudier, B., Albiges, L., Chaput, N.

Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2021, 32, pp.S704-S705. ⟨10.1016/j.annonc.2021.08.083⟩
Annals of Oncology, 2021, 32, pp.S704-S705. ⟨10.1016/j.annonc.2021.08.083⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::73fae92c1bfb57bdbe0195debdbeb999
https://hal.archives-ouvertes.fr/hal-03440287

1924P Targeting microenvironment and cellular immunity in sarcomas with trabectedin combined with metronomic cyclophosphamide: The TARMIC study

Autor: Sun, C-M., Hernandez, I., Ceruso, M. Spalato, Toulmonde, M., Sautes-Fridman, C., Fridman, W-H., Bessede, A., Italiano, A.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S1035-S1035